결과 페이지 10 - 부문: 보건의료 업종: 생명공학 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (44)
- Brussels (7)
- BSE (13)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (389)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (16)
- NSE (8)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (39)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (29)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (210)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (15)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
보건의료 (1741)
- {{item.name}}
- 모든 업종
- 보건의료 (1741)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
UCB SA
UNC.F
DE
|
€263.40 304.05 USD |
+0.11
|
€50.14B 57.88B USD | €8.00 9.23 USD | €263.40 304.05 USD | €263.40 304.05 USD | €50.14B 57.88B USD | 32.84 | €8.02 9.26 USD | ||
argenx SE
ARGX.VI
AT
|
€776.40 896.23 USD |
+1.41
|
€48.81B 56.34B USD | €17.00 19.62 USD | €752.80 868.98 USD | €776.40 896.23 USD | €48.81B 56.34B USD | 39.77 | €19.52 22.53 USD | ||
|
argenx SE
1AEA.MU
DE
|
€755.00 871.52 USD |
-1.95
|
€46.95B 54.2B USD | €0.00 0 USD | €755.00 871.52 USD | €755.00 871.52 USD | €46.95B 54.2B USD | 38.59 | €19.56 22.58 USD | ||
|
argenx SE
1AE.F
DE
|
€745.20 860.21 USD |
-2.15
|
€46.34B 53.49B USD | €13.00 15.01 USD | €745.20 860.21 USD | €745.20 860.21 USD | €46.34B 53.49B USD | 38.07 | €19.57 22.59 USD | ||
argenx SE
1AEA.F
DE
|
€740.00 854.21 USD |
-1.33
|
€46.02B 53.12B USD | €3.00 3.46 USD | €740.00 854.21 USD | €740.00 854.21 USD | €46.02B 53.12B USD | 37.94 | €19.50 22.51 USD | ||
Samsung Biologics Co.,Ltd.
207940.KS
KR
|
₩1,286,000 970.72 USD |
-0.92
|
₩60T 44.94B USD | ₩66K 50.05 USD | ₩1,244,000 939.02 USD | ₩1,310,000 988.84 USD | ₩60T 44.94B USD | 0 | ₩0 0 USD | ||
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$78.41 15.89 USD |
0
|
R$209.37B 42.44B USD | R$0.00 0 USD | R$78.41 15.89 USD | R$78.41 15.89 USD | R$209.37B 42.44B USD | 76.12 | R$1.03 0.21 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€253.20 292.28 USD |
-1.4
|
€33.81B 39.02B USD | €7.00 8.08 USD | €253.20 292.28 USD | €253.20 292.28 USD | €33.81B 39.02B USD | 72.96 | €3.47 4.01 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€252.70 291.7 USD |
+0.36
|
€33.74B 38.95B USD | €55.00 63.49 USD | €250.80 289.51 USD | €252.70 291.7 USD | €33.74B 38.95B USD | 73.24 | €3.45 3.98 USD | ||
CSL Limited
CSJ.F
DE
|
€66.02 76.21 USD |
+7.49
|
€31.62B 36.5B USD | €635.00 733 USD | €64.53 74.49 USD | €66.03 76.22 USD | €31.62B 36.5B USD | 12.31 | €5.36 6.19 USD | ||
CSL
CMXHF
US
|
$73.80 — |
+9.25
|
$35.34B — | $100.00 — | $66.00 — | $66.00 — | $35.34B — | 11.96 | $6.17 — | ||
CSL Limited
CSJA.F
DE
|
€14.80 17.08 USD |
+4.96
|
€28.35B 32.73B USD | €100.00 115.43 USD | €14.80 17.08 USD | €14.80 17.08 USD | €28.35B 32.73B USD | 11.04 | €1.34 1.55 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€47.91 55.3 USD |
0
|
€27.59B 31.85B USD | €0.00 0 USD | €47.91 55.3 USD | €47.91 55.3 USD | €27.59B 31.85B USD | 29.03 | €1.65 1.9 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€46.86 54.09 USD |
-1.56
|
€26.98B 31.15B USD | €140.00 161.61 USD | €46.86 54.09 USD | €46.86 54.09 USD | €26.98B 31.15B USD | 28.40 | €1.65 1.9 USD | ||
|
Revolution Medicines, Inc.
42Z.F
DE
|
€124.50 143.71 USD |
-0.4
|
€26.47B 30.55B USD | €56.00 64.64 USD | €124.50 143.71 USD | €124.50 143.71 USD | €26.47B 30.55B USD | 0 | -€6.18 -7.1 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩166,200 125.45 USD |
-0.66
|
₩38T 28.77B USD | ₩555K 419.11 USD | ₩160,000 120.77 USD | ₩167,100 126.13 USD | ₩38T 28.77B USD | 0 | ₩0 0 USD | ||
|
BeOne Medicines AG
49BA.F
DE
|
€222.00 256.26 USD |
-3.48
|
€23.03B 26.59B USD | €20.00 23.09 USD | €222.00 256.26 USD | €222.00 256.26 USD | €23.03B 26.59B USD | 57.81 | €3.84 4.43 USD | ||
Royalty Pharma plc
RPRXN.MX
MX
|
MX$775.06 45.89 USD |
0
|
MX$446.30B 26.43B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$446.30B 26.43B USD | 23.69 | MX$32.71 1.94 USD | ||
|
BioNTech SE
BNTXN.MX
MX
|
MX$1,633.00 96.69 USD |
0
|
MX$412.96B 24.45B USD | MX$0.00 0 USD | MX$1,633.00 96.69 USD | MX$1,633.00 96.69 USD | MX$412.96B 24.45B USD | 0 | -MX$102.06 -6.04 USD | ||
|
BioNTech SE
B1NT34.SA
BR
|
R$28.80 5.84 USD |
+3.6
|
R$117.70B 23.85B USD | R$12.00 2.43 USD | R$27.50 5.57 USD | R$28.80 5.84 USD | R$117.70B 23.85B USD | 0 | -R$1.89 -0.3 USD | ||
|
BioNTech SE
BNTX.VI
AT
|
€77.00 88.88 USD |
+3.49
|
€19.47B 22.48B USD | €20.00 23.09 USD | €74.75 86.29 USD | €77.00 88.88 USD | €19.47B 22.48B USD | 0 | -€5.07 -5.8 USD | ||
BioNTech SE
22UA.F
DE
|
€77.00 88.88 USD |
+1.65
|
€19.47B 22.48B USD | €280.00 323.21 USD | €73.90 85.31 USD | €77.00 88.88 USD | €19.47B 22.48B USD | 0 | -€5.07 -5.8 USD | ||
|
Incyte Corporation
ICY.F
DE
|
€91.34 105.44 USD |
+0.18
|
€18.25B 21.06B USD | €625.00 721.46 USD | €91.34 105.44 USD | €91.34 105.44 USD | €18.25B 21.06B USD | 14.85 | €6.15 7.1 USD | ||
|
Insmed Incorporated
IM8N.SG
DE
|
€83.94 96.89 USD |
+6.13
|
€18.19B 21B USD | €0.00 0 USD | €78.79 90.95 USD | €84.52 97.56 USD | €18.19B 21B USD | 0 | -€5.00 -5.7 USD | ||
|
Roivant Sciences Ltd.
87S.F
DE
|
€24.48 28.26 USD |
-0.93
|
€17.61B 20.33B USD | €331.00 382.08 USD | €24.41 28.18 USD | €24.48 28.26 USD | €17.61B 20.33B USD | 0 | -€0.47 -0.5 USD | ||
|
Incyte Corporation
INCY.MX
MX
|
MX$1,676.03 99.24 USD |
0
|
MX$334.84B 19.83B USD | MX$0.00 0 USD | MX$1,676.03 99.24 USD | MX$1,676.03 99.24 USD | MX$334.84B 19.83B USD | 13.55 | MX$123.69 7.32 USD | ||
|
Insmed Incorporated
IM8N.F
DE
|
€78.77 90.93 USD |
-6.98
|
€17.07B 19.71B USD | €610.00 704.14 USD | €78.77 90.93 USD | €78.77 90.93 USD | €17.07B 19.71B USD | 0 | -€5.00 -5.7 USD | ||
|
Moderna, Inc.
MRNA.MX
MX
|
MX$832.54 49.3 USD |
+2.78
|
MX$330.34B 19.56B USD | MX$204.00 12.08 USD | MX$832.54 49.3 USD | MX$832.54 49.3 USD | MX$330.34B 19.56B USD | 0 | -MX$142.20 -8.4 USD | ||
|
Incyte Corporation
I1NC34.SA
BR
|
R$238.08 48.25 USD |
0
|
R$95.13B 19.28B USD | R$0.00 0 USD | R$238.08 48.25 USD | R$238.08 48.25 USD | R$95.13B 19.28B USD | 12.96 | R$18.36 3.72 USD | ||
Genmab A/S
0MGB.IL
GB
|
DKK 1,618.75 237.34 USD |
+0.14
|
DKK 129.63B 19.01B USD | DKK 33.55K 4.92K USD | DKK 1,581.00 231.81 USD | DKK 1,627.50 238.63 USD | DKK 129.63B 19.01B USD | 22.87 | DKK 70.77 10.38 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€41.28 47.65 USD |
+0.16
|
€16.38B 18.91B USD | €11.00 12.7 USD | €40.05 46.23 USD | €41.28 47.65 USD | €16.38B 18.91B USD | 0 | -€7.06 -8.1 USD | ||
|
Moderna, Inc.
MRNA.VI
AT
|
€41.00 47.33 USD |
+2
|
€16.27B 18.78B USD | €1.10K 1.27K USD | €40.01 46.18 USD | €41.22 47.58 USD | €16.27B 18.78B USD | 0 | -€7.07 -8.1 USD | ||
Moderna, Inc.
0QF.F
DE
|
€40.95 47.26 USD |
+2.12
|
€16.25B 18.75B USD | €500.00 577.17 USD | €39.95 46.11 USD | €40.95 47.26 USD | €16.25B 18.75B USD | 0 | -€7.06 -8.1 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$4.40 — |
0
|
$18.13B — | $250.00 — | $4.40 — | $4.40 — | $18.13B — | 25.88 | $0.17 — | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€8.21 9.48 USD |
+1.2
|
€14.24B 16.44B USD | €900.00 1.04K USD | €7.91 9.13 USD | €8.21 9.48 USD | €14.24B 16.44B USD | 136.83 | €0.06 0.07 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€3.29 3.8 USD |
+0.61
|
€13.55B 15.65B USD | €1.01K 1.16K USD | €3.21 3.7 USD | €3.29 3.8 USD | €13.55B 15.65B USD | 21.93 | €0.15 0.17 USD | ||
|
GENMAB AS N
GE9.DE
DE
|
€216.00 249.34 USD |
+0.65
|
€13.26B 15.31B USD | €1.00 1.15 USD | €212.70 245.53 USD | €216.00 249.34 USD | €13.26B 15.31B USD | 18.91 | €11.42 13.18 USD | ||
Genmab A/S
GNMSF
US
|
$249.00 — |
0
|
$15.29B — | $178.00 — | $249.00 — | $250.00 — | $15.29B — | 18.93 | $13.15 — | ||
|
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€6.35 7.33 USD |
+0.79
|
€13.08B 15.1B USD | €100.00 115.43 USD | €6.35 7.33 USD | €6.35 7.33 USD | €13.08B 15.1B USD | 21.16 | €0.30 0.35 USD | ||
Genmab A/S
GE91.F
DE
|
€21.20 24.47 USD |
-0.93
|
€13.02B 15.02B USD | €10.00 11.54 USD | €21.20 24.47 USD | €21.20 24.47 USD | €13.02B 15.02B USD | 18.59 | €1.14 1.32 USD | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€204.30 235.83 USD |
+3.23
|
€12.83B 14.81B USD | €19.00 21.93 USD | €198.00 228.56 USD | €204.30 235.83 USD | €12.83B 14.81B USD | 2043.00 | €0.10 0.12 USD | ||
Ascendis Pharma A/S
A71.F
DE
|
€206.00 237.79 USD |
0
|
€12.65B 14.6B USD | €60.00 69.26 USD | €206.00 237.79 USD | €206.00 237.79 USD | €12.65B 14.6B USD | 0 | -€3.77 -4.3 USD | ||
ALTEOGEN Inc.
196170.KQ
KR
|
₩347,000 261.93 USD |
+10.16
|
₩19T 14.01B USD | ₩931K 703.07 USD | ₩299,500 226.07 USD | ₩348,000 262.68 USD | ₩19T 14.01B USD | 0 | ₩0 0 USD | ||
Verona Pharma plc
I9SA.F
DE
|
€90.20 104.12 USD |
0
|
€12.13B 14.01B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.13B 14.01B USD | 0 | €0.00 0 USD | ||
Sino Biopharmaceutical Limited
SBMFF
US
|
$0.78 — |
-6.28
|
$13.87B — | $2.00K — | $0.78 — | $0.78 — | $13.87B — | 38.89 | $0.02 — | ||
Exelixis, Inc.
EX9.F
DE
|
€46.03 53.13 USD |
+1.06
|
€11.57B 13.35B USD | €140.00 161.61 USD | €45.23 52.2 USD | €46.03 53.13 USD | €11.57B 13.35B USD | 17.56 | €2.62 3.02 USD | ||
|
BridgeBio Pharma, Inc.
2CL.F
DE
|
€58.35 67.36 USD |
-1.32
|
€11.43B 13.19B USD | €300.00 346.3 USD | €58.35 67.36 USD | €58.35 67.36 USD | €11.43B 13.19B USD | 0 | -€3.25 -3.7 USD | ||
|
Axsome Therapeutics, Inc.
19X.F
DE
|
€212.20 244.95 USD |
-1.62
|
€10.92B 12.61B USD | €71.00 81.96 USD | €212.20 244.95 USD | €212.20 244.95 USD | €10.92B 12.61B USD | 0 | -€3.24 -3.7 USD | ||
|
Financière de Tubize SA
FTD.SG
DE
|
€234.20 270.35 USD |
+2.09
|
€10.42B 12.03B USD | €7.00 8.08 USD | €230.40 265.96 USD | €235.20 271.5 USD | €10.42B 12.03B USD | 112.05 | €2.09 2.41 USD | ||
|
Financière de Tubize SA
FTD.F
DE
|
€228.60 263.88 USD |
+0.18
|
€10.18B 11.75B USD | €100.00 115.43 USD | €228.60 263.88 USD | €228.60 263.88 USD | €10.18B 11.75B USD | 108.85 | €2.10 2.42 USD | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$1,150.00 68.09 USD |
0
|
MX$190.05B 11.25B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$190.05B 11.25B USD | 0 | -MX$28.98 -1.7 USD | ||
|
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$142.02 28.79 USD |
0
|
R$54.90B 11.13B USD | R$0.00 0 USD | R$142.02 28.79 USD | R$142.02 28.79 USD | R$54.90B 11.13B USD | 39.34 | R$3.61 0.73 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$959.00 56.78 USD |
0
|
MX$185.36B 10.98B USD | MX$0.00 0 USD | MX$959.00 56.78 USD | MX$959.00 56.78 USD | MX$185.36B 10.98B USD | 39.53 | MX$24.26 1.44 USD | ||
|
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€412.30 475.93 USD |
+0.73
|
€9.51B 10.97B USD | €10.00 11.54 USD | €399.60 461.27 USD | €412.30 475.93 USD | €9.51B 10.97B USD | 0 | -€11.71 -13.5 USD | ||
|
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€48.82 56.35 USD |
-2.03
|
€9.44B 10.89B USD | €100.00 115.43 USD | €48.82 56.35 USD | €48.82 56.35 USD | €9.44B 10.89B USD | 40.34 | €1.21 1.4 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€48.35 55.81 USD |
-3.26
|
€9.35B 10.79B USD | €6.00 6.93 USD | €48.35 55.81 USD | €49.40 57.02 USD | €9.35B 10.79B USD | 40.29 | €1.20 1.39 USD | ||
|
Sino Biopharmaceutical
SBHMY
US
|
$12.04 — |
0
|
$10.73B — | $1.00 — | $12.98 — | $12.98 — | $10.73B — | 31.67 | $0.38 — | ||
Arrowhead Pharmaceuticals, Inc.
HDP1.F
DE
|
€64.18 74.09 USD |
+5.01
|
€9.04B 10.44B USD | €200.00 230.87 USD | €60.66 70.02 USD | €64.18 74.09 USD | €9.04B 10.44B USD | 0 | -€1.97 -2.2 USD | ||
|
Akeso, Inc.
4RY.F
DE
|
€9.61 11.09 USD |
+0.08
|
€8.85B 10.22B USD | €2.00 2.31 USD | €9.61 11.09 USD | €9.66 11.15 USD | €8.85B 10.22B USD | 0 | -€0.16 -0.1 USD | ||
|
Bio-Techne Corporation
TECH.MX
MX
|
MX$1,064.35 63.02 USD |
0
|
MX$169.12B 10.01B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$169.12B 10.01B USD | 0 | MX$0.00 0 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.48 0.56 USD |
-1.25
|
€8.59B 9.92B USD | €1.36K 1.57K USD | €0.48 0.56 USD | €0.48 0.56 USD | €8.59B 9.92B USD | 24.07 | €0.02 0.02 USD | ||
|
Krystal Biotech, Inc.
4KB.SG
DE
|
€280.00 323.21 USD |
+3.7
|
€8.25B 9.53B USD | €0.00 0 USD | €269.00 310.52 USD | €281.80 325.29 USD | €8.25B 9.53B USD | 43.20 | €6.48 7.48 USD | ||
|
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$157.04B 9.3B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$157.04B 9.3B USD | 0 | -MX$106.00 -6.2 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€269.20 310.75 USD |
-0.15
|
€7.94B 9.16B USD | €2.00 2.31 USD | €269.20 310.75 USD | €269.20 310.75 USD | €7.94B 9.16B USD | 41.60 | €6.47 7.47 USD | ||
|
ALK-Abelló A/S
4AJ0.F
DE
|
€35.62 41.12 USD |
+1.25
|
€7.89B 9.11B USD | €9.00 10.39 USD | €35.62 41.12 USD | €35.62 41.12 USD | €7.89B 9.11B USD | 45.66 | €0.78 0.9 USD | ||
|
Cytokinetics, Incorporated
KK3A.F
DE
|
€57.72 66.63 USD |
-1.13
|
€7.84B 9.05B USD | €270.00 311.67 USD | €57.72 66.63 USD | €57.72 66.63 USD | €7.84B 9.05B USD | 0 | -€5.94 -6.8 USD | ||
|
Bio-Techne Corporation
T1CH34.SA
BR
|
R$9.23 1.87 USD |
0
|
R$43.35B 8.79B USD | R$0.00 0 USD | R$9.23 1.87 USD | R$9.23 1.87 USD | R$43.35B 8.79B USD | 76.91 | R$0.12 0.02 USD | ||
|
ALK-Abelló A/S
AKBLF
US
|
$38.89 — |
0
|
$8.62B — | $105.00 — | $31.35 — | $31.35 — | $8.62B — | 43.21 | $0.90 — | ||
|
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,192.50 70.61 USD |
0
|
MX$141.45B 8.38B USD | MX$0.00 0 USD | MX$1,192.50 70.61 USD | MX$1,192.50 70.61 USD | MX$141.45B 8.38B USD | 23.92 | MX$49.85 2.95 USD | ||
|
Corcept Therapeutics Incorporated
HTD.F
DE
|
€67.18 77.55 USD |
+1.3
|
€7.21B 8.32B USD | €16.00 18.47 USD | €67.18 77.55 USD | €67.18 77.55 USD | €7.21B 8.32B USD | 216.70 | €0.31 0.36 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€60.78 70.16 USD |
-1.17
|
€7.21B 8.32B USD | €50.00 57.72 USD | €60.78 70.16 USD | €60.78 70.16 USD | €7.21B 8.32B USD | 24.60 | €2.47 2.85 USD | ||
Bio-Techne Corporation
TE1.F
DE
|
€45.27 52.26 USD |
-2.27
|
€7.09B 8.18B USD | €13.00 15.01 USD | €45.27 52.26 USD | €45.27 52.26 USD | €7.09B 8.18B USD | 74.21 | €0.61 0.7 USD | ||
Biocon Limited
BIOCON.BO
IN
|
₹416.80 5.04 USD |
+0.66
|
₹675.01B 8.17B USD | ₹57.63K 697.2 USD | ₹412.30 4.99 USD | ₹419.90 5.08 USD | ₹675.01B 8.17B USD | 147.80 | ₹2.82 0.03 USD | ||
ABIVAX Société Anonyme
AAVXF
US
|
$101.25 — |
0
|
$8.07B — | $100.00 — | $101.25 — | $101.25 — | $8.07B — | 0 | -$5.32 — | ||
ABIVAX Société Anonyme
2X1.F
DE
|
€84.25 97.25 USD |
-3.33
|
€6.72B 7.76B USD | €10.00 11.54 USD | €84.25 97.25 USD | €84.25 97.25 USD | €6.72B 7.76B USD | 0 | -€4.61 -5.3 USD | ||
ImmunityBio, Inc.
26CA.F
DE
|
€6.15 7.1 USD |
+1.82
|
€6.44B 7.44B USD | €840.00 969.64 USD | €6.00 6.93 USD | €6.15 7.1 USD | €6.44B 7.44B USD | 0 | -€0.74 -0.8 USD | ||
|
TG Therapeutics, Inc.
NKB2.F
DE
|
€40.00 46.17 USD |
-4.76
|
€6.12B 7.07B USD | €400.00 461.73 USD | €40.00 46.17 USD | €40.00 46.17 USD | €6.12B 7.07B USD | 16.12 | €2.48 2.86 USD | ||
|
Merus N.V.
2GH.F
DE
|
€79.00 91.19 USD |
0
|
€6.11B 7.05B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.11B 7.05B USD | 0 | €0.00 0 USD | ||
Cidara Therapeutics
CDTX
US
|
$221.38 — |
0
|
$6.96B — | $0.00 — | $0.00 — | $0.00 — | $6.96B — | 0 | $0.00 — | ||
|
Merus
MRUS
US
|
$90.00 — |
0
|
$6.83B — | $0.00 — | $0.00 — | $0.00 — | $6.83B — | 0 | $0.00 — | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€39.80 45.94 USD |
-1.97
|
€5.75B 6.63B USD | €0.00 0 USD | €39.80 45.94 USD | €39.80 45.94 USD | €5.75B 6.63B USD | 0 | -€5.98 -6.9 USD | ||
Legend Biotech Corporation
9LB.F
DE
|
€30.20 34.86 USD |
0
|
€5.61B 6.48B USD | €30.00 34.63 USD | €30.00 34.63 USD | €30.40 35.09 USD | €5.61B 6.48B USD | 0 | -€1.20 -1.3 USD | ||
Vaxcyte, Inc.
5VA.F
DE
|
€38.00 43.86 USD |
-1.04
|
€5.49B 6.33B USD | €6.00 6.93 USD | €38.00 43.86 USD | €38.00 43.86 USD | €5.49B 6.33B USD | 0 | -€5.98 -6.9 USD | ||
Centessa Pharmaceuticals plc
260.F
DE
|
€33.40 38.55 USD |
-0.6
|
€5.17B 5.97B USD | €270.00 311.67 USD | €33.40 38.55 USD | €33.80 39.02 USD | €5.17B 5.97B USD | 0 | -€1.55 -1.7 USD | ||
|
Rhythm Pharmaceuticals, Inc.
1RV.F
DE
|
€73.50 84.84 USD |
-2
|
€5.04B 5.82B USD | €49.00 56.56 USD | €73.50 84.84 USD | €73.50 84.84 USD | €5.04B 5.82B USD | 0 | -€2.72 -3.1 USD | ||
Mirum Pharmaceuticals, Inc.
08D.F
DE
|
€79.96 92.3 USD |
-0.3
|
€4.88B 5.63B USD | €15.00 17.32 USD | €79.96 92.3 USD | €80.32 92.72 USD | €4.88B 5.63B USD | 0 | -€11.81 -13.6 USD | ||
Scholar Rock Holding Corporation
2QK.F
DE
|
€37.98 43.84 USD |
-2.91
|
€4.55B 5.25B USD | €510.00 588.71 USD | €37.98 43.84 USD | €37.98 43.84 USD | €4.55B 5.25B USD | 0 | -€2.99 -3.4 USD | ||
SK Biopharmaceuticals Co., Ltd.
326030.KS
KR
|
₩88,500 66.8 USD |
+2.43
|
₩7T 5.23B USD | ₩1M 779.38 USD | ₩82,500 62.27 USD | ₩89,500 67.56 USD | ₩7T 5.23B USD | 0 | ₩0 0 USD | ||
|
RemeGen Co., Ltd.
REG.F
DE
|
€7.27 8.39 USD |
-0.16
|
€4.38B 5.05B USD | €50.00 57.72 USD | €7.27 8.39 USD | €7.27 8.39 USD | €4.38B 5.05B USD | 42.76 | €0.17 0.2 USD | ||
Apellis Pharmaceuticals Inc
1JK.F
DE
|
€34.11 39.37 USD |
0
|
€4.37B 5.04B USD | €10.00 11.54 USD | €34.11 39.37 USD | €34.11 39.37 USD | €4.37B 5.04B USD | 37.48 | €0.91 1.05 USD | ||
3SBio Inc.
83B.F
DE
|
€1.73 2 USD |
-3.4
|
€4.33B 5B USD | €5.02K 5.8K USD | €1.73 2 USD | €1.73 2 USD | €4.33B 5B USD | 3.93 | €0.44 0.51 USD | ||
|
CRISPR Therapeutics AG
CRSPN.MX
MX
|
MX$854.00 50.57 USD |
0
|
MX$84.11B 4.98B USD | MX$4.00 0.24 USD | MX$854.00 50.57 USD | MX$854.00 50.57 USD | MX$84.11B 4.98B USD | 0 | -MX$107.76 -6.3 USD | ||
Ligand Pharmaceuticals Incorporated
LGDN.F
DE
|
€214.00 247.03 USD |
+2.88
|
€4.29B 4.95B USD | €2.00 2.31 USD | €214.00 247.03 USD | €214.00 247.03 USD | €4.29B 4.95B USD | 32.13 | €6.66 7.69 USD | ||
|
Xenon Pharmaceuticals Inc.
XP0.F
DE
|
€44.00 50.79 USD |
-2.65
|
€4.25B 4.91B USD | €100.00 115.43 USD | €44.00 50.79 USD | €44.00 50.79 USD | €4.25B 4.91B USD | 0 | -€4.08 -4.7 USD | ||
|
HLB Co., Ltd.
028300.KQ
KR
|
₩47,400 35.78 USD |
-2.27
|
₩6T 4.69B USD | ₩2M 1.67K USD | ₩41,900 31.63 USD | ₩49,200 37.14 USD | ₩6T 4.69B USD | 0 | ₩0 0 USD | ||
|
Akero Therapeutics
AKRO
US
|
$54.65 — |
0
|
$4.50B — | $0.00 — | $0.00 — | $0.00 — | $4.50B — | 0 | $0.00 — | ||
|
Akero Therapeutics, Inc.
0K4.F
DE
|
€46.53 53.71 USD |
0
|
€3.85B 4.44B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.85B 4.44B USD | 0 | €0.00 0 USD | ||
|
Agios Pharmaceuticals, Inc.
AGIO.MX
MX
|
MX$1,222.00 72.36 USD |
0
|
MX$72.67B 4.3B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$72.67B 4.3B USD | 5.16 | MX$236.58 14.01 USD | ||
|
BB Biotech AG
BBAGF
US
|
$76.06 — |
0
|
$4.19B — | $100.00 — | $33.65 — | $33.65 — | $4.19B — | 5.66 | $13.42 — | ||
|
Alaunos Therapeutics, Inc.
WEK.MU
DE
|
€14.93 17.23 USD |
0
|
€3.59B 4.15B USD | €430.00 496.36 USD | €1.00 1.15 USD | €1.00 1.15 USD | €3.59B 4.15B USD | 0 | -€57.31 -66.1 USD | ||
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
|||||||||||